|
MBTPS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47130000005546E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57969999999841E-05 |
| Normal-vs-Stage2 |
7.000000E-02 |
| Normal-vs-Stage3 |
1.43909999994474E-06 |
| Normal-vs-Stage4 |
2.38950000008842E-07 |
| Stage1-vs-Stage2 |
2.258400E-01 |
| Stage1-vs-Stage3 |
1.388400E-01 |
| Stage1-vs-Stage4 |
4.219800E-02 |
| Stage2-vs-Stage3 |
5.576000E-02 |
| Stage2-vs-Stage4 |
1.522460E-02 |
| Stage3-vs-Stage4 |
3.970400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20960000022019E-07 |
| Normal-vs-AfricanAmerican |
1.726040E-01 |
| Normal-vs-Asian |
9.157900E-04 |
| Caucasian-vs-AfricanAmerican |
6.258100E-02 |
| Caucasian-vs-Asian |
4.190400E-01 |
| AfricanAmerican-vs-Asian |
3.092600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.71659999999419E-05 |
| Normal-vs-Female |
2.09139999995944E-06 |
| Male-vs-Female |
9.442000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04459999999518E-05 |
| Normal-vs-Age(41-60Yrs) |
6.41639999999777E-05 |
| Normal-vs-Age(61-80Yrs) |
1.96642999999996E-05 |
| Normal-vs-Age(81-100Yrs) |
3.392100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.975800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.582200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.182000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.784200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.441000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.981000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.610170E-02 |
| Classical-VS-Follicular |
3.116400E-01 |
| Classical-VS-Other |
5.265200E-01 |
| Classical-VS-Normal |
6.09459999999507E-05 |
| Tall-VS-Follicular |
2.471200E-01 |
| Tall-VS-Other |
6.789400E-01 |
| Tall-VS-Normal |
2.815600000039E-06 |
| Follicular-VS-Other |
8.558400E-01 |
| Follicular-VS-Normal |
3.444400E-04 |
| Other-VS-Normal |
4.637800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11409999999668E-05 |
| Normal-vs-N1 |
2.47520000051793E-07 |
| N0-vs-N1 |
3.565900E-02 |
|
|
